Extension of Time to File SOU

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: RADIUS (see, http://uspto.report/TM/87796289/mark.png)
SERIAL NUMBER: 87796289

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Radius Health, Inc., having an address of
      950 Winter Street
      Waltham, Massachusetts 02451
      United States
      Email: XXXX
Proposed: Radius Health, Inc., having an address of
      950 Winter Street
      Waltham, Massachusetts 02451
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 06/12/2018.

For International Class 005:
Current identification: Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the fifth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Sarah Anne Keefe
      PRIMARY EMAIL FOR CORRESPONDENCE: tmdocketing@wbd-us.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sarah.keefe@wbd-us.com; nicholas.hawkins@wbd-us.com; christina.rhodes@wbd-us.com

Correspondence Information (proposed):
      Sarah Anne Keefe
      PRIMARY EMAIL FOR CORRESPONDENCE: tmdocketing@wbd-us.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sarah.keefe@wbd-us.com; nicholas.hawkins@wbd-us.com; alice.rogers@wbd-us.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /nicholas b hawkins/      Date Signed: 11/18/2020
Signatory's Name: Nicholas Hawkins
Signatory's Position: Associate attorney of record, MD Bar member
Signatory's Phone: 410-545-5827

RAM Sale Number: 87796289
RAM Accounting Date: 11/18/2020

Serial Number: 87796289
Internet Transmission Date: Wed Nov 18 14:19:46 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XX-202011181419467
73267-87796289-7505dbb4ce97c35d7de2b552e
79befca9e4a670435d3a5fc4399bbbb69b08747-
DA-19465304-20201117121019851833